5-HT2A receptor antagonist

This page covers all 5-HT2A receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-HT2A receptor.

Targets

5-HT2A receptor

Phase 3 pipeline (1)

• Eplivanserin (SR46349) · Sanofi · Sexual Health / Urology
  Eplivanserin is a selective serotonin 5-HT2A receptor antagonist that modulates serotonergic signaling to treat sexual dysfunction.

Patent intelligence

• 5 ht2a receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates